{"id":369644,"date":"2025-09-01T20:14:43","date_gmt":"2025-09-01T20:14:43","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-johnson-johnson-3\/"},"modified":"2025-09-01T20:14:43","modified_gmt":"2025-09-01T20:14:43","slug":"how-to-buy-johnson-johnson-3","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/","title":{"rendered":"Johnson &#038; Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Johnson &#038; Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-369644","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Johnson & Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Johnson & Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Johnson & Johnson (0R34) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025-2030 b\u00fcy\u00fcme potansiyeli i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Johnson & Johnson (0R34) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025-2030 b\u00fcy\u00fcme potansiyeli i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile \u00f6\u011frenin."},"intro":"Sa\u011fl\u0131k tarihinin bir par\u00e7as\u0131na sahip olmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Johnson & Johnson sadece bebek pudras\u0131 ve yara bantlar\u0131ndan ibaret de\u011fil\u201460 y\u0131ldan fazla s\u00fcredir s\u00fcrekli temett\u00fc \u00f6deyen 426 milyar dolarl\u0131k bir sa\u011fl\u0131k devi. \u00c7\u0131\u011f\u0131r a\u00e7an ila\u00e7lar, cerrahi robotlar ve stratejik sat\u0131n almalarla JNJ, ba\u015fka yerde zor bulunan hem istikrar hem de b\u00fcy\u00fcme potansiyeli sunuyor. Neden bunun sizin bir sonraki ak\u0131ll\u0131 yat\u0131r\u0131m hamleniz olabilece\u011fini birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Sa\u011fl\u0131k tarihinin bir par\u00e7as\u0131na sahip olmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Johnson & Johnson sadece bebek pudras\u0131 ve yara bantlar\u0131ndan ibaret de\u011fil\u201460 y\u0131ldan fazla s\u00fcredir s\u00fcrekli temett\u00fc \u00f6deyen 426 milyar dolarl\u0131k bir sa\u011fl\u0131k devi. \u00c7\u0131\u011f\u0131r a\u00e7an ila\u00e7lar, cerrahi robotlar ve stratejik sat\u0131n almalarla JNJ, ba\u015fka yerde zor bulunan hem istikrar hem de b\u00fcy\u00fcme potansiyeli sunuyor. Neden bunun sizin bir sonraki ak\u0131ll\u0131 yat\u0131r\u0131m hamleniz olabilece\u011fini birlikte ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Johnson & Johnson Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>1 Eyl\u00fcl 2025 itibar\u0131yla Johnson & Johnson (JNJ) <strong>177,17 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u201422 A\u011fustos 2025'te ula\u015f\u0131lan t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi olan 177,98 $'a \u00e7ok yak\u0131n. Ancak as\u0131l \u00f6nemli olan \u015fu: <strong>21 Ekim 2025<\/strong> sizin i\u00e7in takip edilmesi gereken bir sonraki b\u00fcy\u00fck tarih. Bu tarihte JNJ \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve tarih g\u00f6steriyor ki bu raporlar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebiliyor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 JNJ Hissesini Genellikle Nas\u0131l Hareket Ettirir?<\/h3> <p>Son d\u00f6neme bak\u0131ld\u0131\u011f\u0131nda, JNJ'nin kazan\u00e7 a\u00e7\u0131klamalar\u0131 ciddi i\u015flem f\u0131rsatlar\u0131 yaratm\u0131\u015ft\u0131r:<\/p> <p><strong>16 Temmuz 2025 (2. \u00c7eyrek Kazan\u00e7lar\u0131):<\/strong> Beklentileri a\u015farak hisse ba\u015f\u0131na 2,77 $ EPS ile 2,68 $ beklentiyi ve 23,74 milyar $ gelir ile 22,85 milyar $ tahminini ge\u00e7ti. \u015eirket y\u0131l sonu rehberli\u011fini y\u00fckseltti ve yat\u0131r\u0131mc\u0131lara olumlu sinyaller g\u00f6nderdi.<\/p> <p><strong>Nisan 2025:<\/strong> 14,6 milyar $ de\u011ferindeki Intra-Cellular Therapies sat\u0131n al\u0131m\u0131 tamamland\u0131, yakla\u015f\u0131k 0,7 milyar $ ek sat\u0131\u015f ve 2025 b\u00fcy\u00fcmesini %0,8 h\u0131zland\u0131rd\u0131.<\/p> <p><strong>\u015eubat 2025:<\/strong> G\u00fc\u00e7l\u00fc 4. \u00e7eyrek sonu\u00e7lar\u0131 kurumsal al\u0131mlar\u0131 tetikledi ve hisse \u00e7eyrek boyunca momentum kazand\u0131.<\/p> <p>Desen? Pozitif s\u00fcrprizler genellikle fiyatlar\u0131 birka\u00e7 g\u00fcn i\u00e7inde %2-6 art\u0131r\u0131rken, k\u00fc\u00e7\u00fck ka\u00e7\u0131rmalar bile al\u0131m f\u0131rsat\u0131 yarat\u0131r \u00e7\u00fcnk\u00fc hisse temel g\u00fcc\u00fc sayesinde genellikle h\u0131zla toparlan\u0131r.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Konsolidasyondan Kopu\u015fa<\/h2> <p>Mart 2025'ten itibaren JNJ'nin fiyat hareketi etkileyici bir hikaye anlat\u0131yor:<\/p> <ul> <li><strong>Mart 2025:<\/strong> 164,43 $-165,84 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc\u2014konsolidasyon d\u00f6nemi<\/li> <li><strong>Nisan 2025:<\/strong> 154,98 $-156,31 $ aral\u0131\u011f\u0131nda\u2014sat\u0131n alma sindirme d\u00f6nemi<\/li> <li><strong>May\u0131s 2025:<\/strong> Yakla\u015f\u0131k 155,21 $\u2014destek seviyeleri aray\u0131\u015f\u0131<\/li> <li><strong>Haziran 2025:<\/strong> Yakla\u015f\u0131k 152,75 $\u2014alt s\u0131n\u0131rlar\u0131n testi<\/li> <li><strong>Temmuz 2025:<\/strong> 2. \u00e7eyrek kazan\u00e7lar\u0131 sonras\u0131 kopu\u015f ba\u015flad\u0131<\/li> <li><strong>A\u011fustos 2025:<\/strong> 177 $-181 $ aral\u0131\u011f\u0131na roket y\u00fckseli\u015fi\u2014yeni t\u00fcm zamanlar\u0131n en y\u00fcksekleri<\/li> <\/ul> <p>Haziran diplerinden %17'lik bu y\u00fckseli\u015f tesad\u00fcfi de\u011fildi. \u015eunlar taraf\u0131ndan desteklendi:<\/p> <ul> <li>Intra-Cellular sat\u0131n al\u0131m\u0131n\u0131n ba\u015far\u0131l\u0131 entegrasyonu<\/li> <li>Myastenia gravis i\u00e7in IMAAVY dahil olmak \u00fczere \u00e7ok say\u0131da ila\u00e7 onay\u0131<\/li> <li>Beklentileri a\u015fan g\u00fc\u00e7l\u00fc operasyonel performans<\/li> <li>Y\u00f6netimin g\u00fcvenini g\u00f6steren y\u00fckseltilmi\u015f rehberlik<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu:<\/strong> 200-205 $ (mevcut seviyelerden %16 y\u00fckseli\u015f)<\/li> <li><strong>2026:<\/strong> 207-214 $ (%21 b\u00fcy\u00fcme e\u011filimi)<\/li> <li><strong>2028:<\/strong> 260-293 $ (%65 potansiyel de\u011fer art\u0131\u015f\u0131)<\/li> <li><strong>2030:<\/strong> 304-309 $ (%74 uzun vadeli b\u00fcy\u00fcme)<\/li> <\/ul> <p><strong>Karar: G\u00dc\u00c7L\u00dc AL<\/strong> - Stratejik sat\u0131n almalar, sa\u011flam \u00fcr\u00fcn hatt\u0131 ve y\u00fckseltilmi\u015f rehberlik birle\u015fimi cazip bir yat\u0131r\u0131m f\u0131rsat\u0131 yarat\u0131yor. T\u00fcm zamanlar\u0131n en y\u00fckseklerinden ya\u015fanan mevcut geri \u00e7ekilme cazip bir giri\u015f noktas\u0131 sunuyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Talk Davalar\u0131:<\/strong> 58.000'den fazla dava devam ediyor, 10 milyar dolarl\u0131k anla\u015fma yak\u0131n zamanda reddedildi<\/li> <li><strong>Stelara Rekabeti:<\/strong> Biyobenzerler sat\u0131\u015flar\u0131 a\u015f\u0131nd\u0131r\u0131yor - 2025 2. \u00e7eyrekte %42,7 d\u00fc\u015f\u00fc\u015f<\/li> <li><strong>Reg\u00fclasyon De\u011fi\u015fiklikleri:<\/strong> Yeni FDA y\u00f6netimi onay standartlar\u0131n\u0131 s\u0131k\u0131la\u015ft\u0131rabilir<\/li> <li><strong>Medicare Etkisi:<\/strong> B\u00f6l\u00fcm D yeniden tasar\u0131m\u0131 2025 sat\u0131\u015flar\u0131nda yakla\u015f\u0131k 2 milyar $ kay\u0131p<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Sat\u0131n Alma G\u00fcc\u00fc:<\/strong> 14,6 milyar $ Intra-Cellular anla\u015fmas\u0131 0,7 milyar $ ek sat\u0131\u015f sa\u011fl\u0131yor<\/li> <li><strong>\u0130la\u00e7 Onaylar\u0131:<\/strong> IMAAVY, TAR-200 \u00f6ncelikli inceleme, CARVYKTI olumlu veriler<\/li> <li><strong>\u00dcretim Yat\u0131r\u0131m\u0131:<\/strong> ABD tesislerine 55 milyar $ taahh\u00fcd\u00fc<\/li> <li><strong>Temett\u00fc Kral\u0131:<\/strong> 60+ y\u0131ld\u0131r art arda art\u0131\u015flar ve %3,4 getiri<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n ama hemen ba\u015flay\u0131n<\/strong> - M\u00fckemmel giri\u015f zaman\u0131n\u0131 beklemek yerine haftal\u0131k yat\u0131r\u0131mlarla dolar maliyeti ortalamas\u0131 yap\u0131n<\/li> <li><strong>Kazan\u00e7 uyar\u0131lar\u0131 ayarlay\u0131n<\/strong> - Takviminize 21 Ekim'i i\u015faretleyin ve olas\u0131 volatiliteye haz\u0131rlan\u0131n<\/li> <li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong> - JNJ'nin temett\u00fc ge\u00e7mi\u015fi bunun h\u0131zl\u0131 bir al-sat de\u011fil, tut ve kazan hikayesi oldu\u011funu g\u00f6steriyor<\/li> <li><strong>Esprili not:<\/strong> \"JNJ ticareti bebek pudras\u0131 gibidir - baz\u0131 yasal sorunlar\u0131 olabilir ama herkes g\u00fcvenilirli\u011fi i\u00e7in almaya devam eder!\"<\/li> <\/ol> <h2>\u2705 Johnson & Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir ticaret platformu se\u00e7in<\/td> <td>NYSE eri\u015fimi ve kesirli hisse sunmas\u0131na dikkat edin<\/td> <\/tr> <tr> <td>2<\/td> <td>Do\u011frulamay\u0131 tamamlay\u0131n<\/td> <td>H\u0131zl\u0131 KYC s\u00fcreci i\u00e7in resmi kimlik haz\u0131r bulundurun<\/td> <\/tr> <tr> <td>3<\/td> <td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td> <td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>\"JNJ\" aramas\u0131 yap\u0131n<\/td> <td>Sadece \u015firket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>Limit emri belirleyin<\/td> <td>Piyasa emirlerinden ka\u00e7\u0131n\u0131n; maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td> <\/tr> <tr> <td>6<\/td> <td>\u00dccretleri g\u00f6zden ge\u00e7irin<\/td> <td>D\u00fc\u015f\u00fck veya s\u0131f\u0131r komisyonlu platformlar\u0131 tercih edin<\/td> <\/tr> <tr> <td>7<\/td> <td>Sat\u0131n al\u0131m\u0131 onaylay\u0131n<\/td> <td>Emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td> <\/tr> <tr> <td>8<\/td> <td>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td> <td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 s\u00fcrekli kontrol etmeden takip edin<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option Neden Mant\u0131kl\u0131?<\/h2> <p>Johnson & Johnson (0R34) hisseleri nas\u0131l al\u0131n\u0131r diye d\u00fc\u015f\u00fcn\u00fcrken, Pocket Option yeni ba\u015flayanlar i\u00e7in inan\u0131lmaz eri\u015filebilir yakla\u015f\u0131m\u0131yla \u00f6ne \u00e7\u0131k\u0131yor:<\/p> <p><strong>Sadece 5 $ minimum depozito<\/strong> ile ger\u00e7ek para ile stratejileri risksiz test etmenizi sa\u011flar. Bu, sa\u011fl\u0131k sekt\u00f6r\u00fc yat\u0131r\u0131mlar\u0131n\u0131 daha b\u00fcy\u00fck miktarlara ba\u011flanmadan \u00f6nce denemek i\u00e7in m\u00fckemmeldir.<\/p> <p><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda do\u011frulama<\/strong> tek bir belge y\u00fckleyerek dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flaman\u0131z\u0131 sa\u011flar. Evrak i\u015flerinin temizlenmesini beklerken piyasa f\u0131rsatlar\u0131n\u0131 ka\u00e7\u0131rmak yok.<\/p> <p><strong>Kripto paralar, e-c\u00fczdanlar ve geleneksel banka y\u00f6ntemleri dahil y\u00fczlerce para \u00e7ekme se\u00e7ene\u011fi<\/strong> Johnson & Johnson yat\u0131r\u0131mlar\u0131n\u0131zdan elde etti\u011finiz k\u00e2rlar\u0131 esnek \u015fekilde eri\u015fmenizi sa\u011flar.<\/p> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, JNJ pozisyonunuzu ger\u00e7ek zamanl\u0131 grafikler ve haber ak\u0131\u015flar\u0131 ile kolayca takip etmenizi sa\u011flar; b\u00f6ylece ne zaman pozisyon ekleyece\u011finize veya k\u00e2r alaca\u011f\u0131n\u0131za bilin\u00e7li kararlar verebilirsiniz.<\/p> <h2>\ud83c\udf0d 2025'te Johnson & Johnson: Sa\u011fl\u0131kta Yenilik Motoru<\/h2> <p>Johnson & Johnson Band-Aid miras\u0131yla yetinmiyor. \u015eirket, bir\u00e7ok sa\u011fl\u0131k sekt\u00f6r\u00fcnde hakimiyet kuruyor:<\/p> <ul> <li><strong>%28 pazar pay\u0131<\/strong> t\u0131bbi cihazlarda<\/li> <li><strong>D\u00fcnyada ilk 5<\/strong> ila\u00e7 sekt\u00f6r\u00fcnde<\/li> <li><strong>88,8 milyar $ y\u0131ll\u0131k gelir<\/strong> \u00e7e\u015fitli gelir kaynaklar\u0131yla<\/li> <li><strong>139.800 \u00e7al\u0131\u015fan<\/strong> 60'tan fazla \u00fclkede inovasyonu y\u00f6nlendiriyor<\/li> <\/ul> <p>\u015eirketin stratejik oda\u011f\u0131 onkoloji, imm\u00fcnoloji ve robotik cerrahi gibi y\u00fcksek b\u00fcy\u00fcme alanlar\u0131na kayd\u0131. OTTAVA cerrahi sistemi minimal invaziv prosed\u00fcrlerin gelece\u011fini temsil ederken, CARVYKTI gibi ila\u00e7lar kanser tedavisinde devrim yarat\u0131yor.<\/p> <p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek:<\/strong> Johnson & Johnson'\u0131n Kuzey Karolina \u00fcretim tesisi, insan denet\u00e7ilerden 100 kat daha h\u0131zl\u0131 mikroskobik kontaminantlar\u0131 tespit edebilen yapay zeka destekli kalite kontrol sistemlerine sahip olacak\u2014ila\u00e7 safl\u0131\u011f\u0131n\u0131 sa\u011flarken \u00fcretim maliyetlerini %15 azaltacak.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Johnson &#038; Johnson Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>1 Eyl\u00fcl 2025 itibar\u0131yla Johnson &#038; Johnson (JNJ) <strong>177,17 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u201422 A\u011fustos 2025&#8217;te ula\u015f\u0131lan t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi olan 177,98 $&#8217;a \u00e7ok yak\u0131n. Ancak as\u0131l \u00f6nemli olan \u015fu: <strong>21 Ekim 2025<\/strong> sizin i\u00e7in takip edilmesi gereken bir sonraki b\u00fcy\u00fck tarih. Bu tarihte JNJ \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve tarih g\u00f6steriyor ki bu raporlar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebiliyor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 JNJ Hissesini Genellikle Nas\u0131l Hareket Ettirir?<\/h3>\n<p>Son d\u00f6neme bak\u0131ld\u0131\u011f\u0131nda, JNJ&#8217;nin kazan\u00e7 a\u00e7\u0131klamalar\u0131 ciddi i\u015flem f\u0131rsatlar\u0131 yaratm\u0131\u015ft\u0131r:<\/p>\n<p><strong>16 Temmuz 2025 (2. \u00c7eyrek Kazan\u00e7lar\u0131):<\/strong> Beklentileri a\u015farak hisse ba\u015f\u0131na 2,77 $ EPS ile 2,68 $ beklentiyi ve 23,74 milyar $ gelir ile 22,85 milyar $ tahminini ge\u00e7ti. \u015eirket y\u0131l sonu rehberli\u011fini y\u00fckseltti ve yat\u0131r\u0131mc\u0131lara olumlu sinyaller g\u00f6nderdi.<\/p>\n<p><strong>Nisan 2025:<\/strong> 14,6 milyar $ de\u011ferindeki Intra-Cellular Therapies sat\u0131n al\u0131m\u0131 tamamland\u0131, yakla\u015f\u0131k 0,7 milyar $ ek sat\u0131\u015f ve 2025 b\u00fcy\u00fcmesini %0,8 h\u0131zland\u0131rd\u0131.<\/p>\n<p><strong>\u015eubat 2025:<\/strong> G\u00fc\u00e7l\u00fc 4. \u00e7eyrek sonu\u00e7lar\u0131 kurumsal al\u0131mlar\u0131 tetikledi ve hisse \u00e7eyrek boyunca momentum kazand\u0131.<\/p>\n<p>Desen? Pozitif s\u00fcrprizler genellikle fiyatlar\u0131 birka\u00e7 g\u00fcn i\u00e7inde %2-6 art\u0131r\u0131rken, k\u00fc\u00e7\u00fck ka\u00e7\u0131rmalar bile al\u0131m f\u0131rsat\u0131 yarat\u0131r \u00e7\u00fcnk\u00fc hisse temel g\u00fcc\u00fc sayesinde genellikle h\u0131zla toparlan\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Konsolidasyondan Kopu\u015fa<\/h2>\n<p>Mart 2025&#8217;ten itibaren JNJ&#8217;nin fiyat hareketi etkileyici bir hikaye anlat\u0131yor:<\/p>\n<ul>\n<li><strong>Mart 2025:<\/strong> 164,43 $-165,84 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc\u2014konsolidasyon d\u00f6nemi<\/li>\n<li><strong>Nisan 2025:<\/strong> 154,98 $-156,31 $ aral\u0131\u011f\u0131nda\u2014sat\u0131n alma sindirme d\u00f6nemi<\/li>\n<li><strong>May\u0131s 2025:<\/strong> Yakla\u015f\u0131k 155,21 $\u2014destek seviyeleri aray\u0131\u015f\u0131<\/li>\n<li><strong>Haziran 2025:<\/strong> Yakla\u015f\u0131k 152,75 $\u2014alt s\u0131n\u0131rlar\u0131n testi<\/li>\n<li><strong>Temmuz 2025:<\/strong> 2. \u00e7eyrek kazan\u00e7lar\u0131 sonras\u0131 kopu\u015f ba\u015flad\u0131<\/li>\n<li><strong>A\u011fustos 2025:<\/strong> 177 $-181 $ aral\u0131\u011f\u0131na roket y\u00fckseli\u015fi\u2014yeni t\u00fcm zamanlar\u0131n en y\u00fcksekleri<\/li>\n<\/ul>\n<p>Haziran diplerinden %17&#8217;lik bu y\u00fckseli\u015f tesad\u00fcfi de\u011fildi. \u015eunlar taraf\u0131ndan desteklendi:<\/p>\n<ul>\n<li>Intra-Cellular sat\u0131n al\u0131m\u0131n\u0131n ba\u015far\u0131l\u0131 entegrasyonu<\/li>\n<li>Myastenia gravis i\u00e7in IMAAVY dahil olmak \u00fczere \u00e7ok say\u0131da ila\u00e7 onay\u0131<\/li>\n<li>Beklentileri a\u015fan g\u00fc\u00e7l\u00fc operasyonel performans<\/li>\n<li>Y\u00f6netimin g\u00fcvenini g\u00f6steren y\u00fckseltilmi\u015f rehberlik<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu:<\/strong> 200-205 $ (mevcut seviyelerden %16 y\u00fckseli\u015f)<\/li>\n<li><strong>2026:<\/strong> 207-214 $ (%21 b\u00fcy\u00fcme e\u011filimi)<\/li>\n<li><strong>2028:<\/strong> 260-293 $ (%65 potansiyel de\u011fer art\u0131\u015f\u0131)<\/li>\n<li><strong>2030:<\/strong> 304-309 $ (%74 uzun vadeli b\u00fcy\u00fcme)<\/li>\n<\/ul>\n<p><strong>Karar: G\u00dc\u00c7L\u00dc AL<\/strong> &#8211; Stratejik sat\u0131n almalar, sa\u011flam \u00fcr\u00fcn hatt\u0131 ve y\u00fckseltilmi\u015f rehberlik birle\u015fimi cazip bir yat\u0131r\u0131m f\u0131rsat\u0131 yarat\u0131yor. T\u00fcm zamanlar\u0131n en y\u00fckseklerinden ya\u015fanan mevcut geri \u00e7ekilme cazip bir giri\u015f noktas\u0131 sunuyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Talk Davalar\u0131:<\/strong> 58.000&#8217;den fazla dava devam ediyor, 10 milyar dolarl\u0131k anla\u015fma yak\u0131n zamanda reddedildi<\/li>\n<li><strong>Stelara Rekabeti:<\/strong> Biyobenzerler sat\u0131\u015flar\u0131 a\u015f\u0131nd\u0131r\u0131yor &#8211; 2025 2. \u00e7eyrekte %42,7 d\u00fc\u015f\u00fc\u015f<\/li>\n<li><strong>Reg\u00fclasyon De\u011fi\u015fiklikleri:<\/strong> Yeni FDA y\u00f6netimi onay standartlar\u0131n\u0131 s\u0131k\u0131la\u015ft\u0131rabilir<\/li>\n<li><strong>Medicare Etkisi:<\/strong> B\u00f6l\u00fcm D yeniden tasar\u0131m\u0131 2025 sat\u0131\u015flar\u0131nda yakla\u015f\u0131k 2 milyar $ kay\u0131p<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Sat\u0131n Alma G\u00fcc\u00fc:<\/strong> 14,6 milyar $ Intra-Cellular anla\u015fmas\u0131 0,7 milyar $ ek sat\u0131\u015f sa\u011fl\u0131yor<\/li>\n<li><strong>\u0130la\u00e7 Onaylar\u0131:<\/strong> IMAAVY, TAR-200 \u00f6ncelikli inceleme, CARVYKTI olumlu veriler<\/li>\n<li><strong>\u00dcretim Yat\u0131r\u0131m\u0131:<\/strong> ABD tesislerine 55 milyar $ taahh\u00fcd\u00fc<\/li>\n<li><strong>Temett\u00fc Kral\u0131:<\/strong> 60+ y\u0131ld\u0131r art arda art\u0131\u015flar ve %3,4 getiri<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n ama hemen ba\u015flay\u0131n<\/strong> &#8211; M\u00fckemmel giri\u015f zaman\u0131n\u0131 beklemek yerine haftal\u0131k yat\u0131r\u0131mlarla dolar maliyeti ortalamas\u0131 yap\u0131n<\/li>\n<li><strong>Kazan\u00e7 uyar\u0131lar\u0131 ayarlay\u0131n<\/strong> &#8211; Takviminize 21 Ekim&#8217;i i\u015faretleyin ve olas\u0131 volatiliteye haz\u0131rlan\u0131n<\/li>\n<li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong> &#8211; JNJ&#8217;nin temett\u00fc ge\u00e7mi\u015fi bunun h\u0131zl\u0131 bir al-sat de\u011fil, tut ve kazan hikayesi oldu\u011funu g\u00f6steriyor<\/li>\n<li><strong>Esprili not:<\/strong> &#8220;JNJ ticareti bebek pudras\u0131 gibidir &#8211; baz\u0131 yasal sorunlar\u0131 olabilir ama herkes g\u00fcvenilirli\u011fi i\u00e7in almaya devam eder!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Johnson &#038; Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve kesirli hisse sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Do\u011frulamay\u0131 tamamlay\u0131n<\/td>\n<td>H\u0131zl\u0131 KYC s\u00fcreci i\u00e7in resmi kimlik haz\u0131r bulundurun<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;JNJ&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Limit emri belirleyin<\/td>\n<td>Piyasa emirlerinden ka\u00e7\u0131n\u0131n; maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u00dccretleri g\u00f6zden ge\u00e7irin<\/td>\n<td>D\u00fc\u015f\u00fck veya s\u0131f\u0131r komisyonlu platformlar\u0131 tercih edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Sat\u0131n al\u0131m\u0131 onaylay\u0131n<\/td>\n<td>Emir detaylar\u0131n\u0131 iki kez kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td>\n<td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 s\u00fcrekli kontrol etmeden takip edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option Neden Mant\u0131kl\u0131?<\/h2>\n<p>Johnson &#038; Johnson (0R34) hisseleri nas\u0131l al\u0131n\u0131r diye d\u00fc\u015f\u00fcn\u00fcrken, Pocket Option yeni ba\u015flayanlar i\u00e7in inan\u0131lmaz eri\u015filebilir yakla\u015f\u0131m\u0131yla \u00f6ne \u00e7\u0131k\u0131yor:<\/p>\n<p><strong>Sadece 5 $ minimum depozito<\/strong> ile ger\u00e7ek para ile stratejileri risksiz test etmenizi sa\u011flar. Bu, sa\u011fl\u0131k sekt\u00f6r\u00fc yat\u0131r\u0131mlar\u0131n\u0131 daha b\u00fcy\u00fck miktarlara ba\u011flanmadan \u00f6nce denemek i\u00e7in m\u00fckemmeldir.<\/p>\n<p><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda do\u011frulama<\/strong> tek bir belge y\u00fckleyerek dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flaman\u0131z\u0131 sa\u011flar. Evrak i\u015flerinin temizlenmesini beklerken piyasa f\u0131rsatlar\u0131n\u0131 ka\u00e7\u0131rmak yok.<\/p>\n<p><strong>Kripto paralar, e-c\u00fczdanlar ve geleneksel banka y\u00f6ntemleri dahil y\u00fczlerce para \u00e7ekme se\u00e7ene\u011fi<\/strong> Johnson &#038; Johnson yat\u0131r\u0131mlar\u0131n\u0131zdan elde etti\u011finiz k\u00e2rlar\u0131 esnek \u015fekilde eri\u015fmenizi sa\u011flar.<\/p>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, JNJ pozisyonunuzu ger\u00e7ek zamanl\u0131 grafikler ve haber ak\u0131\u015flar\u0131 ile kolayca takip etmenizi sa\u011flar; b\u00f6ylece ne zaman pozisyon ekleyece\u011finize veya k\u00e2r alaca\u011f\u0131n\u0131za bilin\u00e7li kararlar verebilirsiniz.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Johnson &#038; Johnson: Sa\u011fl\u0131kta Yenilik Motoru<\/h2>\n<p>Johnson &#038; Johnson Band-Aid miras\u0131yla yetinmiyor. \u015eirket, bir\u00e7ok sa\u011fl\u0131k sekt\u00f6r\u00fcnde hakimiyet kuruyor:<\/p>\n<ul>\n<li><strong>%28 pazar pay\u0131<\/strong> t\u0131bbi cihazlarda<\/li>\n<li><strong>D\u00fcnyada ilk 5<\/strong> ila\u00e7 sekt\u00f6r\u00fcnde<\/li>\n<li><strong>88,8 milyar $ y\u0131ll\u0131k gelir<\/strong> \u00e7e\u015fitli gelir kaynaklar\u0131yla<\/li>\n<li><strong>139.800 \u00e7al\u0131\u015fan<\/strong> 60&#8217;tan fazla \u00fclkede inovasyonu y\u00f6nlendiriyor<\/li>\n<\/ul>\n<p>\u015eirketin stratejik oda\u011f\u0131 onkoloji, imm\u00fcnoloji ve robotik cerrahi gibi y\u00fcksek b\u00fcy\u00fcme alanlar\u0131na kayd\u0131. OTTAVA cerrahi sistemi minimal invaziv prosed\u00fcrlerin gelece\u011fini temsil ederken, CARVYKTI gibi ila\u00e7lar kanser tedavisinde devrim yarat\u0131yor.<\/p>\n<p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek:<\/strong> Johnson &#038; Johnson&#8217;\u0131n Kuzey Karolina \u00fcretim tesisi, insan denet\u00e7ilerden 100 kat daha h\u0131zl\u0131 mikroskobik kontaminantlar\u0131 tespit edebilen yapay zeka destekli kalite kontrol sistemlerine sahip olacak\u2014ila\u00e7 safl\u0131\u011f\u0131n\u0131 sa\u011flarken \u00fcretim maliyetlerini %15 azaltacak.<\/p>\n"},"faq":[{"question":"Johnson & Johnson hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131z\u0131 fonlay\u0131n, JNJ sembol\u00fc ile arama yap\u0131n, limit emri belirleyin ve sat\u0131n alma i\u015flemini onaylay\u0131n."},{"question":"Johnson & Johnson hisseleri i\u00e7in riskler nelerdir?","answer":"Talk davalar\u0131, Stelara rekabeti, reg\u00fclasyon de\u011fi\u015fiklikleri ve Medicare etkisi gibi riskler bulunmaktad\u0131r."},{"question":"Johnson & Johnson hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 200-205 $, 2026'da 207-214 $, 2028'de 260-293 $ ve 2030'da 304-309 $ aral\u0131\u011f\u0131nda b\u00fcy\u00fcme beklenmektedir."},{"question":"Yeni ba\u015flayanlar i\u00e7in en iyi yat\u0131r\u0131m stratejisi nedir?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131p d\u00fczenli yat\u0131r\u0131mlar yapmak, kazan\u00e7 uyar\u0131lar\u0131 ayarlamak ve uzun vadeli d\u00fc\u015f\u00fcnmek en iyi stratejidir."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama ve \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ile yeni ba\u015flayanlar i\u00e7in eri\u015filebilir ve esnek bir platformdur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Johnson & Johnson hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131z\u0131 fonlay\u0131n, JNJ sembol\u00fc ile arama yap\u0131n, limit emri belirleyin ve sat\u0131n alma i\u015flemini onaylay\u0131n."},{"question":"Johnson & Johnson hisseleri i\u00e7in riskler nelerdir?","answer":"Talk davalar\u0131, Stelara rekabeti, reg\u00fclasyon de\u011fi\u015fiklikleri ve Medicare etkisi gibi riskler bulunmaktad\u0131r."},{"question":"Johnson & Johnson hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 200-205 $, 2026'da 207-214 $, 2028'de 260-293 $ ve 2030'da 304-309 $ aral\u0131\u011f\u0131nda b\u00fcy\u00fcme beklenmektedir."},{"question":"Yeni ba\u015flayanlar i\u00e7in en iyi yat\u0131r\u0131m stratejisi nedir?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131p d\u00fczenli yat\u0131r\u0131mlar yapmak, kazan\u00e7 uyar\u0131lar\u0131 ayarlamak ve uzun vadeli d\u00fc\u015f\u00fcnmek en iyi stratejidir."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama ve \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ile yeni ba\u015flayanlar i\u00e7in eri\u015filebilir ve esnek bir platformdur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Johnson &amp; Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson &amp; Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson &amp; Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson &amp; Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T20:14:43+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Johnson &#038; Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Johnson &#038; Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-09-01T20:14:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/\",\"name\":\"Johnson & Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-09-01T20:14:43+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson &#038; Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Johnson &#038; Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Johnson & Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/","og_locale":"tr_TR","og_type":"article","og_title":"Johnson & Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T20:14:43+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Johnson &#038; Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Johnson &#038; Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-09-01T20:14:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/","name":"Johnson & Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-09-01T20:14:43+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Johnson &#038; Johnson (0R34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Johnson &#038; Johnson (0R34) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":369645,"slug":"how-to-buy-johnson-johnson-3","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Johnson & Johnson (0R34) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Johnson & Johnson (0R34)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-johnson-johnson-3\/"},"pt_AA":{"locale":"pt_AA","id":369647,"slug":"how-to-buy-johnson-johnson-3","post_title":"Como comprar a\u00e7\u00f5es da Johnson & Johnson (0R34) - Investimento em a\u00e7\u00f5es da Johnson & Johnson (0R34)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-johnson-johnson-3\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/369644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=369644"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/369644\/revisions"}],"predecessor-version":[{"id":369646,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/369644\/revisions\/369646"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=369644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=369644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=369644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}